Sponsored Links
| Basilea's Toctino(R) Receives Marketing Authorization In Canada |
 |
 |
 |
| Medical News - Dermatology | |||
|
Basilea Pharmaceutica Ltd. announces that Toctino® (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has obtained regulatory approval from Health Canada... Read more: Dermatology News From Medical News Today
|